期刊
CELLS TISSUES ORGANS
卷 201, 期 6, 页码 412-422出版社
KARGER
DOI: 10.1159/000445855
关键词
Mesenchymal stem cells; Peripheral blood; Granulocyte colony-stimulating factor; Mobilization; Differentiation; Spinal cord injury
资金
- Science and Technology Program of Guizhou Province [LKZ2011-19]
- Tackle Key Problems in Science and Technology of Guizhou Province [SY2012-3124]
- National Natural Science Foundation of China [81060148]
Mesenchymal stem cells (MSCs) have been isolated from many tissues and organs. However, there is much dispute as to whether MSCs exist in peripheral blood. This may be due to the limited identification methods of MSCs, especially the lack of detection markers for phenotypic characteristics. In this study, as many as 10 surface markers of MSCs derived from rat peripheral blood (rPBMSCs) were analyzed after granulocyte colony-stimulating factor mobilization. Our results suggest that mobilized rPBMSCs overexpress mesenchymal markers, including CD90, CD44, CD29, CD73 and CD105, but do not express CD45, CD11b, CD79a, CD34 or HLA-DR. This is in conformity with the standard definition of MSCs by the International Society for Cellular Therapy. In addition, the colony-forming efficiency of the mobilized rat peripheral blood was 15.83 +/- 1.61/10(6), significantly outnumbering that of the nonmobilized group, which was 0.28 +/- 0.1/10(6) (p < 0.01). Combining the growth characteristics with the differential capacities of mobilized rPBMSCs towards forming osteocytes, chondrocytes and adipocytes, we further confirmed the existence of rPBMSCs. Additionally, this treatment could improve locomotive function after spinal cord injury (SCI) in rats. Due to their convenient collection, fewer complications, cost effectiveness and suitability for autograft, PBMSCs might be a substitute for MSCs derived from bone marrow and provide promising prospects for the cell-based therapy of SCI. (C) 2016 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据